Friday, June 24, 2016 7:37:39 PM
From CCEL's 8K filed today.
"Stock Purchase Agreement. On June 20, 2016, Cryo-Cell International, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Agreement”) with Ki Yong Choi and Michael Cho (the “Sellers”), collectively the parties (the “Parties”). Pursuant to the Agreement, the Company will purchase 2,179,068 Shares from Ki Yong Choi and 13,416 Shares from Michael Cho (the “Shares”) for $4.50 per share, $9,866,178 in the aggregate (the “Purchase Price”), to be funded through the proceeds of a term loan for approximately $8 million in senior credit facilities and the remainder through the working capital of the Company."
Recent CCEL News
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results • Business Wire • 04/15/2024 09:00:00 PM
- Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value • Business Wire • 03/25/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 10:20:13 PM
- Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 • Business Wire • 02/28/2024 10:00:00 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/12/2023 09:01:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 09:00:21 PM
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results • Business Wire • 10/12/2023 08:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 08:30:34 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 09/15/2023 03:30:08 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/14/2023 08:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 08:17:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/14/2023 09:11:16 PM
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results • Business Wire • 07/14/2023 08:15:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM